Corrigendum to “Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Hospitalization for Heart Failure and Amputation Rate Compared With Incretin-Based Therapy in Patients With Diabetic Foot Disease: A Nationwide Population-Based Study” [Endocrine Practice 30 (2024) 424-430]

IF 3.7 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Endocrine Practice Pub Date : 2024-09-01 DOI:10.1016/j.eprac.2024.06.012

Yi-Hsuan Lin MD , Chia-Hung Lin MD, PhD , Yu-Chih Lin MD , Yu-Yao Huang MD, PhD , An-Shun Tai PhD , Shih-Chen Fu PhD , Sheng-Hsuan Lin MD, ScD, ScM

引用次数: 0

查看原文本刊更多论文

葡萄糖钠转运体 2 抑制剂与基于胰岛素的疗法相比可降低糖尿病足病患者因心力衰竭住院的风险和截肢率：一项基于全国人口的研究》[《内分泌实践》30 (5) (2024) 第 424-430 页]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Endocrine Practice ENDOCRINOLOGY & METABOLISM-

CiteScore

7.60

自引率

2.40%

发文量

546

审稿时长

41 days

期刊介绍： Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.